About Ozempic

Ozempic, a GLP-1 agonist, works by increasing insulin release, delaying gastric emptying, and reducing appetite.

Ozempic is used to lower blood sugar levels and reduce the risk of major cardiovascular events in patients with type 2 diabetes.

While Ozempic was initially designed to help blood sugar levels and is not a weight loss drug, Ozempic’s ingredient semaglutide was approved for weight management by the FDA in 2021. This new branding of semaglutide for weight loss has been named Wegovy. Ozempic is available only by prescription. It is available in a generic formulation as well as under different brand names, including semaglutide.

Ozempic may be prescribed as an injection. It’s always important to follow the specific instructions on your prescription, as they can vary based on the formulation and dosage prescribed.


If you're prescribed Ozempic, be sure to complete the full course of the GLP-1 agonist unless your doctor specifically tells you to stop. If you don’t complete your prescription, Ozempic may not fully treat your type 2 diabetes or weight-related medical problems.

Type 2 diabetes mellitus

Ozempic is FDA-approved as an adjunctive therapy with diet and exercise to control blood sugar in adults with type 2 diabetes. Ozempic can also help reduce the risk of major cardiovascular events, such as heart attacks and stroke, in adults with type 2 diabetes and cardiovascular disease.

Ozempic is not recommended for adults with type 1 diabetes.

Weight loss

Although technically not approved for weight loss, Ozempic may sometimes be prescribed as an “off label” prescription for weight management for certain patients. This may include patients with abnormal blood glucose, patients with prediabetes or metabolic syndrome, or in overweight patients (BMI > 27) with at least one-weight related condition, such as type 2 diabetes or high blood pressure, as well as obese patients (BMI > 30).